Nabriva Gets Initial Nod For $3M Investor Settlement

Law360 (January 29, 2021, 2:07 PM EST) -- A Manhattan federal judge gave an initial nod to a $3 million settlement that would end investor claims that biopharmaceutical company Nabriva Therapeutics PLC and four of its executives misrepresented the company's prospects for getting federal approval for a new antibiotic.

In the Thursday order, U.S. District Judge Victor Marrero granted preliminary approval to a settlement deal, finding that the proposed settlement is "sufficiently fair, reasonable, and adequate, and that there is sufficient likelihood" he'll be able to grant final approval after members of the settlement class have been notified of the pending agreement.

In the order, Judge Marrero also appointed...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


Subscribers Only

Nature of Suit

Subscribers Only


Subscribers Only

Date Filed

Subscribers Only

Law Firms

Government Agencies

Judge Analytics

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!